STE - STERIS PLC Stock Price, Fair Value and News

200.22USD+1.21 (+0.61%)Market Closed

Market Summary

USD200.22+1.21

Market Closed

0.61%

STE Stock Price

View Fullscreen

STE RSI Chart

STE Valuation

Market Cap

19.8B

Price/Earnings (Trailing)

34.9

Price/Sales (Trailing)

3.66

EV/EBITDA

16.37

Price/Free Cashflow

33.31

STE Price/Sales (Trailing)

STE Profitability

Operating Margin

45.49%

EBT Margin

12.62%

Return on Equity

8.84%

Return on Assets

4.96%

Free Cashflow Yield

STE Fundamentals

STE Revenue

Revenue (TTM)

5.4B

Rev. Growth (Yr)

14.77%

Rev. Growth (Qtr)

3.97%

STE Earnings

Earnings (TTM)

566.8M

Earnings Growth (Yr)

13.66%

Earnings Growth (Qtr)

22.05%

Breaking Down STE Revenue

Last 7 days

-4.3%

Last 30 days

-12.9%

Last 90 days

-9.2%

Trailing 12 Months

9.0%

How does STE drawdown profile look like?

STE Financial Health

Current Ratio

2.43

Debt/Equity

0.5

Debt/Cashflow

0.29

STE Investor Care

Dividend Yield

0.99%

Dividend/Share (TTM)

1.98

Buy Backs (1Y)

0.47%

Diluted EPS (TTM)

5.71

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	5.0B	5.1B	5.2B	5.4B
2022	4.6B	4.8B	4.8B	4.8B
2021	3.1B	3.4B	3.8B	4.2B
2020	3.0B	3.0B	3.0B	3.1B
2019	2.8B	2.8B	2.9B	3.0B
2018	2.0B	2.0B	2.7B	2.7B
2017	2.6B	2.5B	2.3B	2.2B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of STERIS PLC

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Dec 04, 2023	xilas andrew	sold (taxes)	-19,528	199	-98.00	svp and gm, dental
Dec 04, 2023	xilas andrew	acquired	-	-	333	svp and gm, dental
Oct 09, 2023	xilas andrew	sold (taxes)	-40,194	225	-178	svp and gm, dental
Oct 09, 2023	xilas andrew	acquired	-	-	605	svp and gm, dental
Oct 02, 2023	carestio daniel a	sold (taxes)	-28,015	215	-130	president and ceo
Oct 02, 2023	xilas andrew	sold (taxes)	-18,317	215	-85.00	svp and gm, dental
Oct 02, 2023	zangerle john adam	sold (taxes)	-13,145	215	-61.00	sr. vp, gen counsel, and sec.
Oct 02, 2023	burton karen l	sold (taxes)	-5,603	215	-26.00	vp, controller & cao
Oct 02, 2023	madsen julia	sold (taxes)	-36,850	215	-171	senior vp, life sciences
Jun 02, 2023	burton karen l	sold (taxes)	-26,094	205	-127	vp, controller & cao

Which funds bought or sold STE recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 16, 2024	OneAscent Financial Services LLC	added	6.06	28,000	354,000	0.04%
Apr 16, 2024	FIRETHORN WEALTH PARTNERS, LLC	unchanged	-	6,177	279,451	0.16%
Apr 16, 2024	OneAscent Wealth Management LLC	added	0.78	14,000	465,000	0.18%
Apr 16, 2024	COURIER CAPITAL LLC	unchanged	-	8,817	398,831	0.03%
Apr 16, 2024	Allred Capital Management, LLC	added	11.52	64,843	526,528	0.21%
Apr 16, 2024	Financial Management Professionals, Inc.	unchanged	-	-	7,000	-%
Apr 16, 2024	WD RUTHERFORD LLC	unchanged	-	13,043	616,007	0.32%
Apr 16, 2024	Kohmann Bosshard Financial Services, LLC	unchanged	-	9,790	442,895	0.06%
Apr 16, 2024	Stratos Wealth Partners, LTD.	added	3.86	188,115	3,222,170	0.05%
Apr 16, 2024	Asset Dedication, LLC	unchanged	-	3,000	77,000	0.01%

Are Funds Buying or Selling STE?

Are funds buying STE calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own STE

No. of Funds

Unveiling STERIS PLC's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	12.01%	11,864,459	SC 13G/A
Feb 09, 2024	blackrock inc.	10.3%	10,135,140	SC 13G/A
Feb 09, 2024	massachusetts financial services co /ma/	5.9%	5,811,818	SC 13G/A
Jan 30, 2024	wcm investment management, llc	4.9%	4,850,134	SC 13G/A
Dec 06, 2023	blackrock inc.	10.2%	10,064,203	SC 13G/A
Feb 10, 2023	wcm investment management, llc	5.6%	5,563,771	SC 13G/A
Feb 09, 2023	vanguard group inc	11.99%	11,966,040	SC 13G/A
Feb 08, 2023	blackrock inc.	8.7%	8,710,879	SC 13G
Feb 08, 2023	massachusetts financial services co /ma/	5.0%	5,038,403	SC 13G
Feb 03, 2022	blackrock inc.	8.1%	8,128,575	SC 13G/A

Recent SEC filings of STERIS PLC

View All Filings

Date Filed	Form Type	Document
Apr 11, 2024	8-K	Current Report
Feb 23, 2024	3	Insider Trading
Feb 13, 2024	SC 13G/A	Major Ownership Report
Feb 09, 2024	SC 13G/A	Major Ownership Report
Feb 09, 2024	SC 13G/A	Major Ownership Report
Feb 08, 2024	10-Q	Quarterly Report
Feb 07, 2024	8-K	Current Report
Jan 30, 2024	SC 13G/A	Major Ownership Report

Peers (Alternatives to STERIS PLC)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	183.7B	40.1B	-5.83%	1.66%	32.1	4.58	-8.12%	-17.45%
BDX	67.1B	19.5B	-2.32%	-8.43%	53.41	3.44	4.02%	-22.04%
ALGN	22.6B	3.9B	-4.99%	-13.70%	50.69	5.84	3.42%	23.09%
BAX	20.1B	14.8B	-4.86%	-7.71%	7.56	1.35	2.12%	209.17%
MID-CAP
ATR	9.1B	3.5B	-0.64%	16.68%	32.11	2.62	4.97%	18.89%
HSIC	9.0B	12.3B	-5.34%	-15.09%	21.69	0.73	-2.44%	-22.68%
BIO	8.5B	2.7B	-12.68%	-39.24%	-13.34	3.18	-4.68%	82.43%
XRAY	6.3B	4.0B	-7.94%	-25.15%	-46.81	1.59	1.10%	85.84%
AXNX	3.4B	366.4M	-1.55%	17.10%	-564.66	9.35	33.86%	89.83%
PDCO	2.3B	6.6B	-3.92%	-2.28%	11.91	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-5.32%	-19.06%	-1.85	0.39	7.73%	-1066.14%
ANIK	382.1M	166.7M	1.82%	-7.51%	-4.62	2.29	6.67%	-456.34%
ANGO	253.5M	324.0M	17.44%	-27.90%	-1.32	0.78	-3.19%	-337.41%
APYX	45.7M	52.3M	-25.42%	-56.00%	-2.44	0.87	17.61%	19.28%
AEMD	3.7M	3.7M	-14.97%	255.00%	-0.3	0.99	5.77%	8.23%

STERIS PLC News

Latest updates

STERIS PLC Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	4.0%	1,396	1,342	1,285	1,385	1,216	1,201	1,156	1,211	1,209	1,197	968	874	809	756	669	823	774	737	697	768	696
Cost Of Revenue	5.9%	793	749	711	-	694	668	639	-	671	717	542	-	463	426	382	459	443	418	391	433	409
Gross Profit	1.5%	603	594	573	588	521	532	518	572	538	480	426	380	346	330	287	363	331	319	307	335	287
Operating Expenses	-5.2%	386	408	385	363	331	839	359	480	335	364	412	236	199	189	172	206	189	192	196	194	217
S&GA Expenses	-5.3%	361	381	359	336	305	323	335	454	311	345	394	221	182	173	155	189	173	176	179	173	176
R&D Expenses	-4.2%	26.00	27.00	26.00	26.00	26.00	25.00	25.00	26.00	25.00	19.00	18.00	18.00	16.00	16.00	16.00	17.00	16.00	16.00	16.00	16.00	15.00
EBITDA Margin	-1.1%	0.26*	0.26*	0.17*	0.17*	0.16*	0.16*	0.25*	0.21*	0.20*	0.19*	0.20*	0.25*	-	-	-	-	-	-	-	-	-
Interest Expenses	5.4%	39.00	37.00	32.00	31.00	29.00	26.00	23.00	22.00	23.00	23.00	22.00	10.00	9.00	9.00	9.00	10.00	10.00	10.00	10.00	11.00	11.00
Income Taxes	13.4%	38.00	34.00	34.00	8.00	37.00	-17.83	24.00	19.00	39.00	20.00	-7.07	49.00	25.00	28.00	19.00	25.00	29.00	22.00	15.00	24.00	9.00
Earnings Before Taxes	19.4%	179	150	158	195	160	-333	135	71.00	182	90.00	-28.98	136	139	134	109	148	134	117	99.00	133	58.00
EBT Margin	-0.6%	0.13*	0.13*	0.04*	0.03*	0.01*	0.01*	0.10*	0.07*	0.09*	0.09*	0.11*	0.17*	-	-	-	-	-	-	-	-	-
Net Income	22.0%	141	115	124	187	124	-315	111	52.00	144	70.00	-21.81	87.00	115	106	90.00	123	105	95.00	85.00	109	48.00
Net Income Margin	-0.3%	0.10*	0.11*	0.02*	0.02*	-0.01*	0.00*	0.08*	0.05*	0.07*	0.06*	0.08*	0.13*	-	-	-	-	-	-	-	-	-
Free Cashflow	174.4%	172	63.00	215	144	114	21.00	116	99.00	163	94.00	41.00	113	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q1
Assets	1.4%	11,435	11,281	10,784	10,822	10,800	10,490	11,188	11,424	11,690	11,752	12,101	6,574	6,581	5,493	5,364	5,441	5,336	5,186	5,230	5,073	5,200
Current Assets	2.1%	2,219	2,174	2,031	2,011	1,977	1,888	1,848	1,879	1,927	1,905	2,008	1,212	1,176	1,150	1,097	1,224	1,053	1,032	1,044	1,054	990
Cash Equivalents	-8.5%	196	214	209	208	259	258	316	348	359	383	535	221	253	312	256	320	199	226	238	221	202
Inventory	4.2%	856	821	769	695	694	645	620	575	595	565	593	315	294	279	277	264	252	237	234	208	206
Net PPE	5.8%	1,844	1,744	1,726	1,706	1,671	1,572	1,573	1,553	1,522	1,511	1,499	1,235	1,227	1,176	1,148	1,112	1,103	1,066	1,054	1,032	1,011
Goodwill	1931.5%	4,112	202	3,887	3,879	3,853	3,705	4,321	4,404	5,115	5,133	5,287	3,026	2,927	2,418	2,372	2,356	2,404	2,319	2,347	2,323	2,434
Liabilities	-1.7%	5,007	5,091	4,606	4,735	4,751	4,676	4,769	4,879	5,066	5,208	5,516	2,683	2,703	1,830	1,874	2,023	1,940	1,948	1,985	1,887	1,983
Current Liabilities	4.6%	914	873	887	862	796	873	908	922	904	786	1,145	578	506	435	480	504	451	428	433	465	398
Short Term Borrowings	10.6%	78.00	71.00	63.00	60.00	60.00	151	151	143	128	22.00	7.00	-	-	-	35.00	-	-	-	-	-	-
Long Term Debt	-4.0%	3,231	3,366	2,860	3,019	3,002	2,874	2,846	2,945	3,175	3,422	3,257	1,651	1,713	1,021	1,022	1,151	1,137	1,187	1,210	1,183	1,316
LT Debt, Non Current	-4.0%	3,231	3,366	2,860	3,019	3,002	2,874	2,846	2,945	3,175	3,422	3,257	1,651	1,713	1,021	1,022	1,151	1,137	1,187	1,210	1,183	1,316
Shareholder's Equity	3.7%	6,415	6,189	6,178	6,077	6,049	5,813	6,419	6,545	6,624	6,545	6,585	3,891	3,891	3,675	3,503	13.00	3,396	3,238	3,245	8.00	11.00
Retained Earnings	4.3%	2,134	2,046	1,981	1,912	1,771	1,695	2,057	1,999	1,990	1,893	1,875	1,939	1,873	1,787	1,700	1,659	1,544	1,473	1,397	1,339	1,146
Shares Outstanding	0.0%	99.00	99.00	99.00	99.00	99.00	100	100	100	100	100	100	85.00	-	-	-	-	-	-	-	-	-
Minority Interest	14.5%	13.00	11.00	10.00	10.00	10.00	11.00	12.00	12.00	12.00	9.00	10.00	10.00	11.00	15.00	15.00	13.00	13.00	9.00	8.00	8.00	11.00
Float	-	-	-	-	-	-	16,561	-	-	-	20,355	-	-	-	14,958	-	-	-	12,164	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	99.4%	291,243	146,095	281,129	215,799	205,578	103,824	231,746	171,731	244,314	171,340	97,426	187,855	205,712	161,951	134,122	199,233	131,326	150,663	109,337	178,926	133,877
Share Based Compensation	-26.2%	15,293	20,716	11,579	9,094	9,346	11,548	8,963	9,751	9,999	11,310	26,600	6,042	6,023	7,939	5,962	4,949	5,586	7,739	5,537	5,608	5,419
Cashflow From Investing	80.4%	-118,921	-606,237	-66,596	-77,578	-98,410	-97,925	-109,417	93,576	-79,800	-76,803	-603,532	-118,256	-923,040	-46,139	-66,724	-59,746	-74,531	-101,151	-84,307	-73,662	-71,406
Cashflow From Financing	-142.1%	-197,994	470,214	-213,637	-191,947	-120,409	-44,948	-141,414	-274,608	-189,265	-239,107	818,810	-96,913	641,852	-65,319	-134,000	-9,272	-90,345	-55,922	-7,607	-110,984	-43,947
Dividend Payments	0.0%	51,378	51,368	46,427	46,600	46,917	46,973	43,008	43,051	43,011	42,959	34,148	34,141	34,136	34,089	31,471	31,439	31,375	31,397	28,823	28,753	28,745
Buy Backs	355.6%	2,228	489	8,724	154,613	84,030	45,243	24,679	28,149	2,877	14,081	10,670	86.00	127	138	14,296	10,920	2,454	22,981	14,886	25,239	354

STE Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Revenues:
Revenues	$ 1,395,645	$ 1,215,994	$ 4,022,547	$ 3,573,002
Cost of revenues:
Total cost of revenues	793,052	694,497	2,252,964	2,001,372
Gross Profit	602,593	521,497	1,769,583	1,571,630
Operating expenses:
Selling, general, and administrative	360,518	305,141	1,100,227	962,962
Goodwill impairment loss	0	0	0	490,565
Research and development	25,913	25,514	78,459	75,193
Restructuring Costs	6	39	2	127
Total operating expenses	386,437	330,694	1,178,688	1,528,847
Income from operations	216,156	190,803	590,895	42,783
Non-operating expenses, net:
Interest expense	38,947	28,559	108,248	77,356
Interest income and miscellaneous expense	(2,080)	1,906	(4,710)	3,200
Total non-operating expenses, net	36,867	30,465	103,538	80,556
Income before income tax expense	179,289	160,338	487,357	(37,773)
Income tax expense	38,344	37,013	106,276	43,378
Net Income	140,945	123,325	381,081	(81,151)
Less: Net Income Attributable to Noncontrolling Interest	202	(503)	1,465	(956)
Net Income (Loss) Attributable to Shareholders	$ 140,743	$ 123,828	$ 379,616	$ (80,195)
Net income per common share [Abstract]
Basic	$ 1.42	$ 1.24	$ 3.84	$ (0.80)
Diluted	1.42	1.24	3.82	(0.80)
Cash dividends declared per common share outstanding	$ 0.52	$ 0.47	$ 1.51	$ 1.37
Product [Member]
Revenues:
Revenues	$ 804,756	$ 679,042	$ 2,280,950	$ 1,982,512
Cost of revenues:
Cost of Goods and Services Sold	439,005	374,729	1,223,415	1,058,663
Service [Member]
Revenues:
Revenues	590,889	536,952	1,741,597	1,590,490
Cost of revenues:
Cost of Goods and Services Sold	$ 354,047	$ 319,768	$ 1,029,549	$ 942,709

STE Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Current assets:
Cash and cash equivalents	$ 195,585	$ 208,357
Accounts receivable (net of allowances of $27,951 and $23,427, respectively)	964,022	928,315
Inventories, net	855,617	695,493
Prepaid expenses and other current assets	203,729	179,277
Total current assets	2,218,953	2,011,442
Property, plant, and equipment, net	1,844,484	1,705,512
Operating Lease, Right-of-Use Asset	195,413	191,741
Goodwill	4,111,683	3,879,219
Intangible Assets, Net (Excluding Goodwill)	2,987,287	2,955,780
Other assets	77,335	78,145
Total assets	11,435,155	10,821,839
Current liabilities:
Accounts payable	276,730	279,620
Accrued income taxes	24,880	43,804
Accrued payroll and other related liabilities	178,838	125,642
Capital Lease Obligations, Current	36,711	34,961
Short-term Debt	78,438	60,000
Accrued expenses and other	318,097	317,817
Total current liabilities	913,694	861,844
Long-term indebtedness	3,231,075	3,018,655
Deferred Income Taxes and Other Tax Liabilities, Noncurrent	621,071	617,538
Capital Lease Obligations, Noncurrent	162,827	160,493
Other Liabilities, Noncurrent	78,389	76,137
Total liabilities	5,007,056	4,734,667
Commitments and contingencies (see Note 8)
Common shares, with $0.001 par value; 500,000 authorized; 98,808 shares issued; and 98,629 shares outstanding, respectively.	4,534,259	4,486,375
Retained earnings	2,133,766	1,911,533
Accumulated other comprehensive income	(252,629)	(320,710)
Total shareholders' equity	6,415,396	6,077,198
Noncontrolling interest	12,703	9,974
Total equity	6,428,099	6,087,172
Total liabilities and equity	$ 11,435,155	$ 10,821,839

About STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

CEO	Mr. Daniel A. Carestio
WEBSITE	steris.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	17000

STERIS PLC Frequently Asked Questions

What is the ticker symbol for STERIS PLC? What does STE stand for in stocks?

STE is the stock ticker symbol of STERIS PLC. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of STERIS PLC (STE)?

As of Wed Apr 17 2024, market cap of STERIS PLC is 19.78 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of STE stock?

You can check STE's fair value in chart for subscribers.

What is the fair value of STE stock?

You can check STE's fair value in chart for subscribers. The fair value of STERIS PLC is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of STERIS PLC is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for STE so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is STERIS PLC a good stock to buy?

The fair value guage provides a quick view whether STE is over valued or under valued. Whether STERIS PLC is cheap or expensive depends on the assumptions which impact STERIS PLC's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for STE.

What is STERIS PLC's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 17 2024, STE's PE ratio (Price to Earnings) is 34.9 and Price to Sales (PS) ratio is 3.66. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. STE PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on STERIS PLC's stock?

In the past 10 years, STERIS PLC has provided 0.159 (multiply by 100 for percentage) rate of return.